that's how I see it. Just the message could have been bit more clear.
Otherwise it is common sense to save money if the company generated enough targets (based on visuals and dependent on assay results) to design second round of drilling.
Also, there is no point of laying down any plans of what and how the second round will be developing if assay results are not in and review is not completed.
Ann: Chairman's Update - August 2022, page-108
-
- There are more pages in this discussion • 77 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ICG (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.438M | |||
| Open | High | Low | Value | Volume |
| 0.8¢ | 0.8¢ | 0.8¢ | $4.21K | 526.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1242857 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 1677291 | 4 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| ICG (ASX) Chart |